Advertisement
Moderna is charging $37 a dose for its experimental vaccine

Moderna Charging Much More for COVID-19 Vaccine Than Others

0
Vaccine currently in phase 3 trials; company confident it will be available by the end of the year
In patients who have previously suffered a vertebral fracture

Longer Bisphosphonate Drug Holiday May Up Fracture Risk

0
For those with previous vertebral fracture, major osteoporotic fractures increased with holidays >12 months
Almost half of older U.S. adults report being screened for colorectal

Overscreening for Cancer Common Among Older Adults

0
Findings seen across cancer types, particularly for women living in U.S. metropolitan areas
In clinical practice guidelines from the American Society of Colon and Rectal Surgeons

ASCRS Updates Guidelines on Surgery for Crohn Disease

0
Surgery may be considered for those with inadequate response to, nonadherence with medical therapy
Since 2009

Diabetes-Related Lower-Limb Amputations Up in Older Adults

0
Absolute rates for amputation among Medicare beneficiaries highest in oldest old, blacks, men
Cannabis seems not to be associated with cardiovascular benefits but has adverse cardiovascular effects

AHA: Cannabis May Have Adverse Cardiovascular Effects

0
No indication of cardiovascular benefits found; more research needed to further understand adverse effects
Dermatological disorders are extremely common in older individuals

Skin Conditions Common in Older Adults

0
Authors urge whole-body skin examinations for geriatric patients
American Indian and Alaska Native adults are more likely to be in fair or poor health than all U.S. adults

CDC: More American Indian, Alaska Natives in Fair, Poor Health

0
18.9 percent of AIAN adults have a disability in large MSAs versus 12.9 percent in rural areas
As the COVID-19 pandemic intensified

ED Visits Decreased in Five States From January Through April 2020

0
Increase in admission rates from the ED seen during same period, with largest relative increase in NY
The U.S. government will pay Johnson & Johnson $1 billion for 100 million doses of its vaccine if it is approved by the U.S. Food and Drug Administration

Johnson & Johnson Makes $1 Billion Vaccine Deal

0
Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine